The iconic rise of Viagra has consistently remained a symbol of pharmaceutical success, yet its legacy within the broader sector now triggers questions about long-term gains. Alternative versions are undercutting market share, causing anxieties that supporting companies significantly dependent to Viagra's former position could be a speculative m… Read More